Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaginal microbicides.

Rebecca Flynn O'Brien1

  • 1Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, Tufts University School of Medicine, The Floating Hospital for Children at Tufts-New England Medical Center, Boston, MA 02111, USA. robrien@tufts-nemc.org

Adolescent Medicine Clinics
|October 13, 2006
PubMed
Summary

Developing new topical microbicides is crucial for women's health due to the HIV pandemic and lack of vaccines. The ideal microbicide must be safe, effective, and prevent viral resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical conditions with psychiatric manifestations.

Adolescent medicine clinics·2006
Same author

Bacterial vaginosis: many questions--any answers?

Current opinion in pediatrics·2005
See all related articles

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • The global HIV/AIDS pandemic necessitates novel prevention strategies.
  • Lack of effective vaccines against HIV and other sexually transmitted infections (STIs) highlights the need for alternative prophylactics.
  • Women's vulnerability and challenges in condom negotiation underscore the importance of female-controlled prevention methods.

Purpose of the Study:

  • To review the current status of topical microbicide development for HIV prevention.
  • To identify the challenges and requirements for safe and effective microbicide compounds.
  • To discuss the progress and future prospects of microbicide candidates.

Main Methods:

  • Literature review of current microbicide research and development.
  • Analysis of factors driving microbicide development, including HIV transmission dynamics and STI roles.
  • Evaluation of criteria for an ideal microbicide: safety, efficacy, and prevention of resistance.

Main Results:

  • Significant progress has been made in understanding HIV transmission and the role of STIs.
  • Several microbicide candidates are in development, with clinical trials anticipated.
  • Key challenges remain in ensuring safety, high efficacy, and avoiding disruption of host defenses.

Conclusions:

  • Topical microbicides represent a promising prophylactic option for women, particularly in high-prevalence settings.
  • Continued research and development are essential to overcome challenges and bring effective microbicides to market.
  • Advancements in scientific understanding are paving the way for the next generation of HIV prevention tools.

Related Experiment Videos